23 C
New York
Sunday, June 14, 2026

Tag: society

newssourceFORcompanyinformationcontent1marketreleases

BrainStorm to Announce Second Quarter Financial Results and Provide a Corporate Update

Call Scheduled for August 14, 2025, at 8:30 AM Eastern Time NEW YORK, Aug. 8, 2025 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (OTCQB: BCLI), a leading...

Xuan Wu Cloud Donates Computers to Support Rural Education, Actively Fulfilling Social Responsibility

GUANGZHOU, China, Aug. 8, 2025 /PRNewswire/ -- Recently, Xuan Wu Cloud (2392.HK) donated 40 computer systems, valued at 100,000 RMB, to schools with limited resources...

Vancouver’s Ruby Slippers Production Society takes centre stage with new federal funding

Parliamentary Secretary Taleeb Noormohamed announces support for an initiative empowering diverse voices in Canadian theatre VANCOUVER, BC, Aug. 7, 2025 /CNW/ - Canada's arts and...

Wheaton Precious Metals Announces Record Revenue and Operating Cash Flow for the Second Quarter of 2025

SECOND QUARTER FINANCIAL RESULTS VANCOUVER, BC, Aug. 7, 2025 /PRNewswire/ - "Wheaton delivered another outstanding quarter, achieving record revenue, adjusted net earnings, and operating cash...

Wheaton Precious Metals Announces Record Revenue and Operating Cash Flow for the Second Quarter of 2025

SECOND QUARTER FINANCIAL RESULTS VANCOUVER, BC, Aug. 7, 2025 /CNW/ - "Wheaton delivered another outstanding quarter, achieving record revenue, adjusted net earnings, and operating cash...

Nuvalent Highlights Pipeline and Business Achievements, Reiterates Key Anticipated Milestones, and Reports Second Quarter 2025 Financial Results

Initiated rolling NDA submission for zidesamtinib for TKI pre-treated patients with advanced ROS1-positive NSCLC, with target completion in the third quarter of 2025 Initiated ALKAZAR...

Implantica announces second publication of groundbreaking 5-year results from the landmark RefluxStop® clinical study

VADUZ, Liechtenstein, Aug. 7, 2025 /PRNewswire/ -- Implantica AG (publ), a leading medtech company pioneering advanced implantable medical technologies, today announced the second peer-reviewed...

Bangchak Corporation Public Company Limited’s Phra Khanong Community Relations: A Model for Social Empowerment

BANGKOK, Aug. 7, 2025 /PRNewswire/ -- The Bangchak Corporation Public Company Limited's Phra Khanong Community Relations initiative has been recognized as a standout success, earning...

SIGGRAPH 2025 Ignites Global AI Dialogue Across Art, Science, and Industry

Conference Unites Diverse Disciplines to Explore the Expanding Role of Artificial Intelligence in Creativity, Computation, and Connection. VANCOUVER, BC, Aug. 6, 2025 /PRNewswire/ -- From...

Urothelial Carcinoma Market Set to Expand During the Forecast Period (2025-2034) Amid Rising Incidence and Evolving Therapeutic Landscape | DelveInsight

The dynamics of the urothelial carcinoma market are anticipated to change due to the demand for innovative therapies, particularly in chemotherapy and immunotherapy, and...

Urothelial Carcinoma Market Set to Expand During the Forecast Period (2025-2034) Amid Rising Incidence and Evolving Therapeutic Landscape | DelveInsight

The dynamics of the urothelial carcinoma market are anticipated to change due to the demand for innovative therapies, particularly in chemotherapy and immunotherapy, and...

CLK Inhibitors Market Poised for Growth as Demand Rises in Oncology and Musculoskeletal Disorders | DelveInsight

The CLK inhibitors market is projected to expand in the coming years, driven by a rising incidence of cancer diagnoses, growing awareness of these...

CLK Inhibitors Market Poised for Growth as Demand Rises in Oncology and Musculoskeletal Disorders | DelveInsight

The CLK inhibitors market is projected to expand in the coming years, driven by a rising incidence of cancer diagnoses, growing awareness of these...

Jazz Pharmaceuticals Announces U.S. FDA Approval of Modeyso™ (dordaviprone) as the First and Only Treatment for Recurrent H3 K27M-mutant Diffuse Midline Glioma

Modeyso is the first treatment option for this ultra-rare and aggressive brain tumor, which primarily affects children and young adults Accelerated approval based on an...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsSociety

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers